Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways.
Saved in:
| Title: | Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways. |
|---|---|
| Authors: | Tang SE; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan.; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Liao WI; Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Pao HP; The Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan., Hsu CW; Department of Emergency and Critical Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan., Wu SY; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan., Huang KL; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan.; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Chu SJ; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Jul 15; Vol. 12, pp. 650573. Date of Electronic Publication: 2021 Jul 15 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2021.650573 |